BDNF in sleep, insomnia, and sleep deprivation

Author(s): Schmitt K, Holsboer-Trachler E, EC-Kert A

Abstract

The protein brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors involved in plasticity of neurons in several brain regions. There are numerous evidence that BDNF expression is decreased by experiencing psychological stress and that, accordingly, a lack of neurotrophic support causes major depression. Furthermore, disruption in sleep homeostatic processes results in higher stress vulnerability and is often associated with stress-related mental disorders. Recently, we reported, for the first time, a relationship between BDNF and insomnia and sleep deprivation (SD). Using a biphasic stress model as explanation approach, we discuss here the hypothesis that chronic stress might induce a deregulation of the hypothalamic-pituitary-adrenal system. In the long-term it leads to sleep disturbance and depression as well as decreased BDNF levels, whereas acute stress like SD can be used as therapeutic intervention in some insomniac or depressed patients as compensatory process to normalize BDNF levels. Indeed, partial SD (PSD) induced a fast increase in BDNF serum levels within hours after PSD which is similar to effects seen after ketamine infusion, another fast-acting antidepressant intervention, while traditional antidepressants are characterized by a major delay until treatment response as well as delayed BDNF level increase.

Similar Articles

The non-cognitive features of dementia

Author(s): Allen NHP, Burns A

Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Author(s): Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Engchild J, et al.

Protein folding assisted by chaperones

Author(s): Borges JC, Ramos CH

Heat shock protein 70 in Alzheimer's disease

Author(s): Lu RC, Tan MS, Wang H, Xie AM, Yu JT, et al.

BDNF is essential to promote persistence of long-term memory storage

Author(s): Bekinstein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, et al.

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease

Author(s): Philips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, et al.

The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients

Author(s): Ciaramella A, Salani F, Bizzoni F, Orfei MD, Langella Rangelucci F, et al.

Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?

Author(s): Fahnestock M, Garzon D, Holsinger RM, Michalski B

BDNF and full-length and truncated TrkB expression in Alzheimer disease

Author(s): Ferreer I, Marin C, Rey MJ, Ribalta T, Goutane, et al.

The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease

Author(s): Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, et al.

Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease

Author(s): Nacmias B, Tedde A, Forleo P, Piacentini S, Guamieri BM, et al.